Figure 5.
Kaplan–Meier analysis for the three-RBPs prognostic signature in breast cancer. (A) Survival Kaplan–Meier estimate of the three-RBPs prognostic signature in the TCGA-BRCA database (n = 1,088) and METABRIC database (n = 1,893), in which clinical samples were grouped by Youden index of risk score; (B), ROC curve for assessing the reliability of the model; (C) Survival Kaplan–Meier estimate of the three-RBPs prognostic signature in the GSE20685 database (n = 327), the GES4922 database (n = 249) as well as the FUSCC database (n = 360), in which samples were grouped by Youden index of risk score. OS, overall survival; DFS, disease-free survival; RFS, recurrence-free survival. P <0.05 was considered as statistically significant.